Replies to post #7284 on GTC Biotherapeutics (fka GTCB)

[DewDiligence]

The Laureate relationship is also very old news.

[rustyboy]

JesseL:

This is just from memory but I believe this agreement provides a potential 'second source' for final purification, lyophilization, fill and finish. Cambrex is doing that job now for Atyrn but perhaps GTC is planning for higher future higher volume requirements for Atryn (:>) ..as well as the ability to handle other products. Also, GTC did have to write off some inventory at the end of Q2 due to some manufacturing problem at their fill and finish contractor so
having a 'second source' seems only prudent.

[biopearl]

Jessie, I too was blown away by this news only it happened to me about 3 years ago when they announced it. It was reminescent of the Lonza announcement which of course was followed by silence. Just like the Malaria press releases. We hear about what is happening or about to happen but never when it goes on hold or just dissapears. So who knows? bp